P PHARMA SAUDI (SAMPLE) COMPANY LTD Report Viewed on May 16,2016
Subscriber ID: 923000002 Ticket Key: 201605165009233579 Customer Ref: D&B DUNS : 557655375 COMPANY NAME : P PHARMA SAUDI (SAMPLE) COMPANY LTD ADDRESS : Al Solaiman Building Medina Road Jeddah Saudi Arabia TELEPHONE : (966) (2) (88678908) (966) (2) (88567891) FAX : (966) (2) (88567896) WEB PAGE : www.starph.com EMAIL :
[email protected] REGISTRATION # : 1012220003 START DATE : 11/Oct/1994 CONTROL DATE : 11/Oct/1994 HISTORY : Clear EMPLOYEES (Total) : 14 IMPORTS : Yes EXPORTS : Yes INCOME : SAR 22,372,928 NET WORTH (Tangib : SAR 10,933,795 AUTHORIZED CAPITA : SAR 3,000,000 ISSUED CAPITAL : SAR 3,000,000 PAIDUP CAPITAL : SAR 3,000,000
CHIEF EXECUTIVE : Abdul Al Solaiman Chairman SIC 5047 0000 5122 0000 LOB Wholesales medical and hospital equipment CURRENCY: All amounts in this report are in local currency unless otherwise stated.
Risk Assessment Risk Indicator
3
D&B Rating
2A3 Based on tangible Net
Fair
1
Financial Strength
2A Based on tangible Net Worth
Risk Indicator
3
4
Fair
The Dun & Bradstreet Rating of 2A3 indicates: A Financial Strength of USD 2.5 12 million (based on Net Worth) and a Risk Indicator which is Fair
CURRENT INVESTIGATION On 27/Apr/2016, Saud Al Sulaiman, Managing Director, confirmed all information in this report . On 27/Apr/2016, Saud Al Sulaiman, Managing Director, stated that: Comments :
Other Comments: The correct name, address and contact details of the Subject company are as updated in the report. Other Comments: The financial details in this report has been obtained from annual reports of the Subject which were provided by the Respondent.
FINANCE Comparative Figures of Saudi Riyal Date 31/Dec/2012 31/Dec/2013 31/Dec/2014 Fiscal Fiscal Fiscal Current: Assets 10,423,310 12,943,317 13,087,362 Liabilities 2,919,776 3,481,021 2,693,188 Working Cap. 7,503,534 9,462,296 10,394,174 Other : Tangible Assets 866,193 574,202 606,022 Liabilities 54,232 66,401 Net Worth 8,369,727 9,982,266 10,933,795 Annual Sales 25,369,146 21,011,201 22,372,928 Profit After Tax 1,668,990 1,046,236 1,136,120 Inventory 624,330 951,419 405,560 Cash & Bank 908,792 2,219,830 3,959,960 A/Cs Receivable 8,278,308 9,033,859 6,681,871 Fixed Assets 866,193 574,202 390,116 A/Cs Payable 2,813,976 3,378,189 2,623,753
Fiscal Balance Sheet as of 31/Dec/2014 (in Saudi Riyal) Cash & Bank 3,959,960 Accounts Payable 2,623,753
Inventory 405,560 Current Portion of Accounts Receivable 6,681,871 Long Term Debt 39,435 Loans & Advances 1,358,927 Other Payables / Accruals 30,000 Margin Deposit 681,044 TOTAL CURRENT LIAB 2,693,188 TOTAL CURRENT ASSETS 13,087,362 Loans Secured 18,159 Property, Plant & End of Service Gratuity 48,242 Equipment 57,938 Transportation Vehicles 116,253 TOTAL NONCURRENT LIAB 66,401 Furniture Fixtures & Fitting 160,599 Office Equipment 53,176 Capital 3,000,000 Display Equipments 2,150 Retained Earnings (loss) 8,264,408 Statutory Reserves 939,444 TOTAL FIXED ASSETS 390,116 Current Account 1,270,057 TOTAL EQUITY 10,933,795 Investment in Affiliates 215,906 TOTAL INVESTMENTS 215,906
TOTAL ASSETS 13,693,384 TOTAL LIAB & EQUITY 13,693,384 Profit & Loss Account Figures in Saudi Riyal Date 31/Dec/2012 31/Dec/2013 31/Dec/2014 No. of Months 12 12 12 Fiscal Fiscal Fiscal Consolidated Income 25,369,146 21,011,201 22,372,928 Less: Cost of Sales 20,377,275 16,392,181 17,397,922 Gross Profit 4,991,871 4,619,020 4,975,006 General Operating Expenses 2,876,409 3,128,025 3,375,181 Depreciation/Amortisation 375,940 394,442 401,134 Net Operating Profit(Loss) after Depreciation before Interest 1,739,522 1,096,553 1,198,691 Other Nonoperating Income 4,234 6,266 6,022 Total Financial Expenses 74,766 56,583 68,593 Net Operating Profit before Tax and after Extraordinary Items 1,668,990 1,046,236 1,136,120 Profit Before Tax and After Extraordinary Item 1,668,990 1,046,236 1,136,120 Income Tax / Other Taxes 0 0 0 Profit (Loss) After Tax 1,668,990 1,046,236 1,136,120 Net Profit After Tax and Extraordinary Items 1,668,990 1,046,236 1,136,120 Less: Dividends 166,899 104,624 113,612 Plus (Minus) Retained Earnings (Loss) b/f 4,798,197 6,300,288 7,241,900 Retained Earnings (Loss) c/f 6,300,288 7,241,900 8,264,408 Accounts are audited by ERNST & YOUNG. 2012 2013 2014
GROWTH TREND Sales Growth (%) 17.17 6.48 Net Profit Growth (%) 8.59 SOLVENCY Current Ratio 3.56 3.71 4.85 Quick Ratio 3.14 3.23 3.95 Total Liabilities to Net Worth Ratio (%) 34.88 35.41 25.23 EFFICIENCY Collection Period (Days) 117 154 107 Sales to Inventory (Times) 40 22 55 PROFITABILITY Return on Sales (%) 6.57 4.97 5.07 Return on Net worth (%) 19.94 10.48 10.39
BANK Information in this report may not represent the full extent of subject's bank relationships. Banking relations are maintained principally with: NAME :DDD BANK
No independent confirmations were obtainable from banker/(s). INSURANCE COMPANY : A.H.H
REGISTRATION DETAILS LEGAL STRUCTURE :Limited liablity company REGISTERED :11 Oct 1994 REGISTRATION BODY :Economic Development Board FILE NUMBER :1012220003 Jeddah Saudi Arabia CHAMBER OF COMMERCE NUMBER :70574 LAST FINANCIAL STATEMENT DATE :31/Dec/2014
Registry details provided by :search at local registry office CAPITAL DETAILS AUTHORIZED CAPITAL :SAR 3,000,000.00 ISSUED CAPITAL :SAR 3,000,000.00 PAIDUP CAPITAL :SAR 3,000,000.00 as of 1/Feb/2015 ORDINARY SHARES :SAR 3,000,000.00 at par value 10.00 SHAREHOLDER(S) The following details represent the Full Shareholders List.
ORDINARY SHARES Name of Shareholder Location % Held Abdul Al Solaiman Saudi Arabia 75 Saud Al Solaiman Saudi Arabia 25
Total No. of shareholder : 2 Shareholdings as of : 1 Feb 2015 AUDITORS ER & NEW Company SOLICITORS David Company
CORPORATE DIRECTORS Name : Abdul Al Solaiman Name : Saud Al Solaiman
EXECUTIVES Name : Abdul Al Solaiman Current Title : Chairman Active in daily operations : Yes Name : Saud Al Solaiman Current Title : Managing Director Active in daily operations : Yes
OPERATIONS 50470000 Wholesales medical and hospital equipment 51220000 Wholesales drugs, proprietaries, and sundries
AGENCIES HELD BRAND NAME Principal Name : Mega Sciences : Australia Subject as : Distributor Description : Ginsomin, Pynocare & Iicare
Principal Name : Bliss Sciences : India Subject as : Distributor Description : TODAY
Principal Name : Kuwai Pharma : Kuwait Subject as : Distributor Description : TODAY
Principal Name : Monday Wellness : United States Subject as : Distributor Description : TODAY
PURCHASES INTERNATIONAL : 100 % IMPORTS FROM: Kuwait India United States Canada Australia
PURCHASING TERMS IMPORT TERMS bank transfer Letter of Credit SALES TERRITORY LOCAL : 20 % INTERNATIONAL : 80 %
EXPORTS TO: Kuwait Uganda Kenya Democratic Republic of Co Nigeria Ghana
SELLING TERMS LOCAL SALES TERMS TERMS : bank transfer
EXPORT TERMS TERMS : cash Letter of Credit (at sight) 90
CUSTOMERS Subject maintains 1000 accounts / customers. MAJOR CUSTOMERS KSP Manufacturer Department Store(s) Kuwait DelMM Distributor Uganda 50 % of Sales Gest Distributor Kenya Gulf A Distributor Congo
SUPPLIERS BL Phar Ltd 102, Hyde Park, Andheri Mumbai India
K SP P.O. Box : 5512 Safat 13056 Kuwait
Mega Life Sciences Australia
EMPLOYEE(s) CURRENT Total Employees : 14 as at 01/Feb/2015
EMPLOYEE(s) PREVIOUS YEAR: : 2014 Total Employees : 12 YEAR: : 2013 Total Employees : 11
ISO CERTIFICATION Subject was awarded ISO 9001 on 28 Dec 2004
LOCATION TYPE OF OCCUPATION: Owned PREMISES USED AS : Administrative office
ADDITIONAL CURRENT ADDRESSES MAILING ADDRESS Postal Box 80513 Jeddah Saudi Arabia
AFFILIATE(s) TOTAL NUMBER OF AFFILIATES : 1 IMEX HEALTH FZC Riyadh Saudi Arabia Subject holds 50 shares in affiliate.
BRANCH(es) Subject maintains 1 branch(es) country wide. The principal branch location(s) are as follows: P.O. Box 23456 Dammam Saudi Arabia Location Type : Warehouse
Area : 1500 Square Feet
Customer Service Speed of Service: Typically 8 working days SCN:
201605165009233579
Order Date:
May 16,2016
Should you require any further information or have any questions, please contact your local C ustomer Service C entre. Enquiries should always contain the below minimum details please: Full company name and address C ontact name and number SC N Order Date The information in this report was last updated on Apr 28,2016
D&B Rating Glossary D&B Rating The D&B rating consists of two parts, the Financial Strength Indicator and the Risk Indicator. For example: in the case of a 2A 4 rating, 2A means the financial strength of the business and the 4 is the risk indicator. The Risk Indicator is used in conjunction with the Financial Strength Indicator. The Risk Indicator reflects D&B's opinion of a company抯 health, stability and overall condition. It takes into consideration all significant elements of credit. Such classification is relative and is predicted on the broad and overall view point. C reated from expert rules systems, the Risk Indicator is refreshed whenever data is loaded onto our databases. Please see the table below for the Risk Indicators and their corresponding values.
Risk Indicators 4 Significant level of risk
Take suitable assurances before extending credit
Assigned to concerns of known financial weakness. A number of years losses, higher than normal working capital deficit, a negative tangible net worth which is the worsening, court judgements, bad payments etc. This risk is associated with being a creditor of these concerns is high or significant
3 Greater than average risk
Proceed with transaction but monitor closely
Assigned to concerns believed to be financially sound but with a history of slow payments or some losses or working capital deficit. The risk associated with being a creditor of these concerns is higher and would be classified as potentially slow payers or fair trade risk
2 Low risk
Proceed with transaction
This is assigned to financially sound concerns, having no known record of bad payments and paying suppliers quickly. The risk associated with being a creditor of these concerns would be low and they would be classified as ordinary trade risk
1 Minimal risk
Proceed with transaction offer terms required
Assigned to companies of undoubted credit standing and financially strength. The risk associated with being a creditor of these concerns would be negligible or zero, the concern which pays bills promptly or discount.
No public information or D&B proprietary information available to indicate trading activity
Assigned to concerns where there is insufficient information to express any opinion on the condition, financial soundness or payment history of the concern. A concern with no telephone number will also be assigned a "" condition
Insufficient information to assign a risk indicator
The Financial Strength Indicator is based on either the Net Worth or Issued C apital. The table below contains the possible values.
Financial Strength Indicator
Range
Net Worth
Capital
FROM
TO
5A
5AA
$60 million
And above
4A
4AA
$25 million
$60 million
3A
3AA
$12 million
$25 million
2A
2AA
$2.5 million
$12 million
1A
1AA
$1.2 million
$2.5 million
A
AA
$600,000
$1.2 million
B
BB
$345,000
$600,000
C
CC
$175,000
$345,000
D
DD
$120,000
$175,000
E
EE
$60,000
$120,000
F
FF
$35,000
$60,000
G
GG
$15,000
$35,000
H
HH
0
$15,000
Alternative Ratings Used N
Financial Strength is negative
O
Financial Strength is undisclosed
NB
New Business: less than 24 months
NQ
Out of Business: Business has ceased to trade
Financial Rating Glossary Name Current Ratio (x)
Solvency Ratio (%)
Fixed Assets to Net Worth (%)
Current Liabilities to Net Worth (%)
Asset Turnover (%)
Formula Total C urrent Assets / Total C urrent Liabilities
((Total C urrent + Deferred + Long Term Liabilities) / Tangible Net Worth) x 100
(Total Fixed Assets / Tangible Net Worth) x 100
(Total C urrent Liabilities / Tangible Net Worth) x 100
(Turnover / Total Assets(including intangibles)) x 100
Explanation This ratio shows the cover by current assets of short term creditors, and the higher the ratio the more assurance there is that payment of creditors can be met From this can be seen the extent to which the company is financed by creditors and debt rather than permanent finance. The higher the ratio the more likely it is that the debt (either short term or long term) will be a burden to the company. The effect is higher interest changes, lower profits and a squeeze on liquidity to the disadvantage of creditors. The proportion of net worth that consists of fixed assets will vary greatly from industry to industry, but in general terms a company is under capitalised if fixed assets exceed net worth. In this case it is possible that the company has too much debt, and it should therefore be examined with care. If on the other hand fixed assets are much lower than net worth the company is over capitalised and is either extremely cautious or in a position to expand. Thus a ratio either well in excess of the median, or well below it, means that the company should be looked at with care. This contrasts the funds that creditors are temporarily risking with a company with the funds permanently invested by the owners. The higher the ratio the less security for creditors. C are should be exercised when selling to any company with creditors of less than one year exceeding two thirds of net worth This ratio measures how efficiently the company's management has been in generating sales from the assets at its disposal. The measure can vary considerably from industry to
intangibles)) x 100
Sales to net working capital (x)
Turnover / Net working capital
The measure can vary considerably from industry to industry and should therefore be judged according to the industry norm. This ratio indicates whether a company is overtrading (handing an excessive volume of sales in relation to working capital). C ompanies with substantial sales gains often reach a level where their working capital becomes strained. Even if they maintain an adequate total investment for the volume being generated (assets to sales) that investment may be so centred in fixed assets or other noncurrent items that it will be difficult to continue meeting all current obligations. A ratio falling into either an extremely high or low position may indicate potential problems.
Confidentiality C ONFIDENTIAL....THIS INFORMATION IS PROVIDED BY DUN & BRADSTREET SUBJEC T TO THE TERMS AND C ONDITIONS OF YOUR SUBSC RIPTION C ONTRAC T AND IS NOT TO BE DISC LOSED. This report is forwarded to the Subscriber in strict confidence for the use by the Subscriber as one factor to consider in connection with credit and other business decisions. This report contains information compiled from information which Dun & Bradstreet does not control and which has not been verified unless otherwise indicated in this report. Dun & Bradstreet therefore cannot accept responsibility for the accuracy, completeness or timeliness of the report. Dun & Bradstreet disclaims all liability for any loss or damage arising out of or in anyway related to the contents of this report. This material is confidential and proprietary to Dun & Bradstreet and/or third parties and may not be reproduced, published or disclosed to others without the express authorization of Dun & Bradstreet or the General C ounsel of Dun & Bradstreet. C OPYRIGHT 2016 DUN & BRADSTREET. THIS REPORT MAY NOT BE REPRODUC ED IN WHOLE OR IN PART IN ANY FORM OR MANNER WHATSOEVER.
